Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,251,771    

Indirect Value

   $375,195,594      
Total Shares   71,480,988      
Total Value   $537,447,365      


Halozyme Therapeutics Inc $162,231,150 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,231,150 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-02-29 4 A $29.67 $999,991 I/I 33,425 105,150 0 -
CLDA Clinical Data Inc Director   –       •       •   2003-11-10 4 A $0.00 $0 I/I 1,411,600 112,890 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-11 4 B $5.27 $608,364 I/I 115,439 115,439 2.25 -
TCRT Alaunos Therapeutics Director   –       •       •   2015-12-31 4 A $0.00 $0 D/D 26,661 122,309 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-03-31 4 A $33.89 $999,963 I/I 29,299 128,548 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-05-09 4/A B $13.42 $233,239 I/I 17,248 129,794 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2013-08-13 4 A $0.00 $4,788,448 I/I 5,399,630 131,081 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-17 4 B $4.69 $425,824 I/I 90,794 145,885 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-20 4 B $4.63 $2,095,084 I/I 452,502 148,329 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-21 4 B $4.74 $428,188 I/I 90,335 148,817 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-04-29 4 A $26.73 $999,963 I/I 28,556 149,622 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-22 4 B $4.70 $812,061 I/I 172,779 149,750 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-23 4 B $4.67 $600,683 I/I 128,626 150,445 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-24 4 B $4.68 $508,459 I/I 108,645 151,032 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-29 4 B $4.68 $878,338 I/I 187,679 152,045 2.64 -
CLDA Clinical Data Inc Director   –       •       •   2006-02-09 4 A $23.40 $3,588,507 I/I 153,355 153,353 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-30 4 B $4.79 $1,473,366 I/I 307,592 153,706 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-31 4 B $4.78 $648,369 I/I 135,642 154,438 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-04 4 B $5.17 $349,900 I/I 67,679 154,803 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-06 4 B $5.23 $1,364,575 I/I 260,913 156,212 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-07 4 B $5.26 $1,169,587 I/I 222,355 157,413 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-17 4 B $2.46 $231,486 I/I 94,100 170,800 1.5 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-12 4 B $5.42 $308,940 I/I 57,000 172,439 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-18 4 B $2.42 $8,470 I/I 3,500 174,300 1.5 -
PGEN Precigen Inc Executive Chairman   •       •       •   2020-01-31 4 B $5.86 $34,999,999 I/I 5,972,696 182,200 2.64 %
  271  Records found
  1   2  3   4   5   6   7   8   9   10   11      
  Page 2 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us